TT

Teena Tummuri

Director DIN 02145068
DIN 02145068 First appointment Oct 2007
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Oct 2007
Shareholding value β€’β€’β€’β€’ Premium profile

About Teena Tummuri

Data last updated:

Teena Tummuri was a Whole-Time Director at Virchow Chemicals Pvt. Ltd (from 2007) and Additional Director at Siri Drugs India Private Limited (from 2015).

DIN 02145068
First Appointment 01 Oct 2007
Oldest Company Age 38 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Virchow Chemicals Pvt. Ltd U65910TG1988PTC008596
Whole-Time Director01 Oct 20071988₹120 Cr (FY 2020)Amalgamated
Siri Drugs India Private Limited U24232AP2012PTC079367
Additional Director17 Oct 20152012Amalgamated

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Virchow Chemicals Pvt. Ltd
Siri Drugs India Private Limited
Premium access

Shareholding and investment profile for Teena Tummuri

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Teena Tummuri

Teena Tummuri was first appointed on 01 Oct 2007 as Whole-Time Director at Virchow Chemicals Pvt. Ltd. The most recent appointment on record is 17 Oct 2015 at Siri Drugs India Private Limited.

Teena Tummuri held 2 earlier board appointments: Virchow Chemicals Pvt. Ltd (Whole-Time Director, from 01 Oct 2007); Siri Drugs India Private Limited (Additional Director, from 17 Oct 2015).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available